📰 Danielle Peyton News
Danielle Peyton News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Danielle Peyton. Real-time updates on events, politics, business and more.
June 13, 2024
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rivian Automoative, Inc....
June 13, 2024
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such
May 31, 2024
Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") and certain officers. The class action, filed in the United States District Court for the District of Maryland, Southern...
May 29, 2024
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NYSE: VSTS). Such...
May 28, 2024
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Luna Innovations Incorporated...
May 28, 2024
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cambium Networks Corporation (“Cambium” or the “Company”) (NASDAQ: CMBM). Such
May 28, 2024
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Sprout Social, Inc. (“Sprout Social” or the…
May 26, 2024
New York, New York--(Newsfile Corp. - May 26, 2024) - Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation (CV...
May 23, 2024
NEW YORK, May 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. and certain officers. The class action, filed in the United States...
May 23, 2024
NEW YORK, May 22, 2024 Pomerantz LLP announces that a class action lawsuit has been filed against Harbor Diversified, Inc. ("Harbor" or the "Company") (OTC: HRBR). Such investors are advised